Other
ECT treatment
ECT treatment is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels
NCT00370058
unknownnot_applicable
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT03651674
completed
Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia
NCT01856010
Clinical Trials (3)
Showing 3 of 3 trials
NCT00370058Phase 4
Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels
NCT03651674Not Applicable
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT01856010
Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3